Thalassemic red cells show irregular morphology and maldistribution of glycoproteins and sialic acids. These changes are compatible with damage to the red cell membrane skeleton. To test this possibility, we systematically studied the interconnections of skeletal proteins in patients with a form of alpha thalassemia (HbH disease), in patients with beta thalassemia intermedia, and in normal individuals. Alpha-and beta-thalassemic spectrin functions normally in spectrin self-association, binding to normal inside-out vesicles (IOVs), and binding to actin in the presence and absence of normal protein 4.1. Binding of normal spectrin to beta:thalassemic IOVs is normal but alpha-thalassemic IOVs are defective and bind only half the normal amount of spectrin (66±5 vs. 120±16 Aig spectrin dimer/mg IOV protein, respectively). A different defect is detected in beta thalassemia, in which protein 4.1 shows markedly reduced ability (48±7% of normal) to enhance the binding of normal spectrin to actin and a decreased ability to bind normal spectrin in a binary interaction, compared with normal protein 4.1 (24±1 and 43±1 tig protein 4.1/mg spectrin, respectively). As no quantitative deficiency of beta-thalassemic protein 4.1 is detected, we assume an acquired lesion is present, which affects about half of the protein 4.1 molecules. These findings indicate that specific, localized, yet different defects exist in the skeletal proteins of alpha-and beta-thalassemic red cells. The different molecular lesions imply that the mechanism of hemolysis and probably the interaction of unpaired globin chains with the membrane differs in the two diseases.
Introduction
Studies ofthe thalassemic syndromes have concentrated intensively on the primary genetic defects in hemoglobin synthesis (1) . The mechanisms leading to the premature destruction of the abnormal red blood cells (RBCs) in the bone marrow sinusoids and the peripheral circulation have not been clearly defined. It is generally assumed that the extra, unmatched globin chains precipitate in the erythrocyte, resulting in widespread membrane dysfunction (see reference 2 for review). Indeed, alterations in the phospholipid and cholesterol content, increased intracellular calcium concentration, and changes in the membrane sialic acid residues have been documented in beta thlalassemia (2) . Thalassemic red cells are more sensitive to oxidant stress, as reflected by an increase in malonyldialdehyde formation, a decrease in polyunsaturated fatty acids (3) , an increase in protein cross-linking (4) , and a decrease in titratable membrane thiols (5) . This oxidant susceptibility may be due to excessive oxidation ofthe unstable globin chains and the subsequent release of oxygen radicals that theoretically might damage any component of the red cell membrane.
The abnormal morphology and irregular shape ofthalassemic red cells suggest that the erythrocyte membrane skeleton must be damaged. The skeletal protein network is thought to be important in regulating different functions, including the deformability and stability ofred cell membranes (6) . Analyses of the latter parameters in thalassemic cells show that whereas both alpha-(HbH)' and beta-thalassemic membranes are unusually rigid, beta-thalassemic membranes are also fragile and fragment twice as rapidly as normal at high shear stress (7) . We have also recently examined the membrane protein skeletons of beta-thalassemic red cells by scanning electron microscopy and found abnormalities in their shape and protein composition (8) .
The goal ofthis study was to characterize the defects in the membrane skeletons of alpha-and beta-thalassemic red cells, and to analyze the similarities and differences between the two syndromes. We therefore studied systematically the major skeletal proteins interactions in patients with alpha and beta thalassemia. We found a qualitative defect in the binding of normal spectrin to inside-out vesicles (IOVs) in alpha thalassemia, and a different defect in the interaction of spectrin, actin, and protein 4.1 in beta thalassemia. The latter is caused by the presence of abnormal protein 4.1 molecules, with reduced ability to bind normal spectrin. These findings indicate that specific, localized skeletal protein damage occurs in thalassemia, and the damage differs in alpha and beta thalassemia.
consent was obtained from all participants. The thalassemic samples were obtained from patients who rarely require blood transfusions. None of the patients had been transfused in the 4 mo preceding the study. The detailed hemoglobin analysis and globin chain synthesis ratios of many ofthe patients have been previously described (9) . Some samples were obtained from Israeli patients, and were shipped on ice by air express, accompanied by a normal control. All blood samples were received and studied within 24-36 h after blood collection. No differences were observed between samples shipped from Jerusalem and samples obtained locally.
Preparation of red cell membranes and membrane proteins. RBC membranes were prepared by hypotonic lysis in 5 mM sodium phosphate, pH 8 (10) with the addition of 1 mM EDTA and protease inhibitors (2 mM diisopropyl fluourophosphate, 5 gg/ml leupeptin) to the lysis buffer. Ratios of various membrane proteins were determined by running RBC membranes on a 3.5-17% exponential SDS-polyacrylamide gel (1 1). In most experiments, the Coomassie Blue-stained bands of spectrin, ankyrin, protein 3, protein 4.1, and globin were cut from four to six lanes, the dye was eluted with 25% pyridine, and the relative protein content was estimated by absorbance at 605 nm (12) .
In some experiments, the ratios were determined by densitometry of Coomassie Blue-stained gels. Spectrin-depleted IOVs were separated from low ionic strength extracts by sedimentation and layered on a Dextran barrier (13) . The sidedness of the IOVs was determined by measuring the glyceraldehyde-3-phosphate dehydrogenase activity before and after the addition of 0.2% Triton X-100, as described by Steck and Kant (14) . Spectrin was isolated by low ionic strength extraction with 0.1 mM sodium phosphate, pH 8, at 370C, and purified by gel filtration chromatography on Agarose A15M 200-400 mesh (Bio-Rad Laboratories, Richmond, CA) as described (15) . Protein 4.1 was purified from fresh red cell membranes by high salt extraction with 1 M KCl, as described by Tyler (16) and modified by Cohen and Foley (17) . Actin was prepared from rabbit skeletal muscle by the method of Spudich and Watt (18) . It has been previously shown that this actin is equivalent to erythrocyte actin in assays of spectrinactin-protein 4.1 interactions ( 19).
The spectrin and protein 4.1 were iodinated with '251I-Bolton
Hunter reagent (New England Nuclear, Boston, MA) (20) . Analysis of protein concentration was performed by the method of Lowry (21) using a BSA standard. Membrane skeletal protein interactions. Spectrin self-association was analyzed by nondenaturing gel electrophoresis at .0C, as described (22) . The proportions of spectrin dimer, tetramers, and oligomers in low temperature (4°C), low ionic strength extracts were studied directly. The interconversion of spectrin tetramers to dimer was also determined during incubation of these extracts for 6 h at 30°C (22) . Interactions of spectrin and ankyrin on IOVs were studied by rebinding 125I-spectrin dimer to spectrin depleted IOVs in 130 mM KCl, 20 mM NaCl, 10 mM sodium phosphate, 1 mM EDTA, 1 mM DTT, 1 mM MgCl2, and 0.5 mM sodium azide, pH 7.5 (buffer A) for 90 min at 0°C. Free and membrane-bound radioactivity was determined by pelleting the IOVs through 20% sucrose in the binding buffer (wt/vol), as described by Goodman and Weidner (23) . Samples of 1251I-spectrin were heat denatured (60°C, 10 min) and tested at various spectrin concentrations in each experiment to estimate the amount of nonspecific binding. Such binding was < 15% of the values of untreated spectrin and was routinely subtracted.
Interaction ofthalassemic spectrin with F actin and protein 4.1 was studied in an assay designed by Wolfe et al. (24) , as modified by Becker et al. (25) , where increasing concentrations of '251-spectrin dimer (10-30 ,ug) were incubated with 24 ,g F actin in the presence or absence of protein 4.1 (0 or 6 ug) in 150 mM NaCl, 4 mM sodium phosphate, 10 mM Tris, 0.5 mM DTT, 0.1 mM ATP, 0.01 mM CaCl2, 4 mg/ml BSA, pH 7.4 (buffer B) for 60 min at 23°C. In a few experiments, designed to test the function of protein 4.1, increasing concentrations of 4.1 (0-3 Mg) were incubated with fixed amounts of '25I-normal spectrin dimer (12 gig) and F actin (21 Mtg) for 1 h at 241C in 130 mM KCl, 20 mM NaCl, 10 mM Tris Cl, 1 mM EDTA, 1 mM NaN3, and 0.1 mM DTT, pH 7.6 (buffer D). In both cases the F actin was then collected by centrifugation (48,000 g for 120 min) through a 10% (wt/vol) sucrose cushion in the binding buffer, and the pellet was counted to determine the amount of bound '251-spectrin. Control samples containing '251-spectrin alone were included in each assay and the nonspecific counts, which did not exceed 5%, were subtracted from the binding data. The assay was also performed in the presence and absence of DTT to test whether thalassemic skeletal proteins had incurred reversible oxidative damage.
In another set of experiments, a fixed amount of normal '251I-spectrin (10 Mg) was incubated with 21 Mg F actin, in the presence of increasing concentrations of thalassemic or normal protein 4.1 (0-3 ag), under the same experimental conditions.
Interaction of spectrin and purified protein 4.1 was studied by binding 1251I-protein 4.1 to speptrin-Sepharose (Pharmacia Fine Chemicals, Piscataway, NJ) in a modification of the method described by Becker et al. (26) . Briefly, normal spectrin dimer (1-2 mg/ml) was attached to CNBr-Sepharose 4B (5 mg spectrin/g dry beads) in 0.1 M sodium bicarbonate and 0.15 M NaCl, pH 8 at 4°C for 16 h mixing end over end. The coupling efficiency was generally > 90%. Control beads were prepared by coupling Sepharose to BSA at the same concentration. These were used to assess nonspecific binding. A fixed amount of spectrin-Sepharose (40 Mg spectrin) or an equivalent amount of BSA-Sepharose was incubated with '251-protein 4.1 (0-18 ,Mg) in 10 mM sodium phosphate, 130 mM KCl, 20 mM NaCl, 1 mM EDTA, 0.5 mM sodium azide, (pH 7.6), 1 mg/ml BSA, and 0.1% NP-40 (Calbiochem-Behring Corp., La Jolla, CA) (buffer C) for 90 min at 0°C. The spectrin-Sepharose or albumin-Sepharose and protein 4.1 mixtures were layered over 20% sucrose in the same buffer, centrifuged at 5,000 rpm for 15 min, and the pellets were assayed for radioactivity.
The nonspecific binding on the BSA-Sepharose was < 10% of the binding values to the spectrin-Sepharose and was subtracted. The purified spectrin and protein 4.1 were clarified by centrifugation at 100,000 g for 45 min before binding in these experiments.
PAGE. PAGE in the presence of SDS was performed using the continuous method of Fairbanks (10) as modified by Steck (27) , and the discontinuous method of Laemmli (28) . PAGE in the absence of detergents was performed on 3% acrylamide tube gels.
Results
Composition of ghosts and vesicles. SDS-PAGE of red cell membranes and spectrin-depleted IOVs from thalassemic patients and normal individuals are shown in Fig. 1 A and B and quantified in. Table I . There is a mild to moderate decrease in the spectrin content of both alpha-thalassemic (13% decrease) and beta-thalassemic (23% decrease) membranes. Similar spectrin deficiency has been observed previously in beta thalassemia by Shinar et al. (18) . There is also an increase in the hemoglobin content of the alpha-and beta-thalassemic membranes, reaching 10±2 and 13+4%, respectively, of the total membrane protein, as calculated by densitometry or pyridine elution. An increase of cytoplasmic proteins, like catalase, is also detected, which has been described for other hemolytic anemias (29) . The protein composition of spectrin-depleted thalassemic and normal IOVs is comparable (Fig. 1 B, Table   I ), except for the presence of hemoglobin, which is normally undetectable, but reaches 0.5-5% of the total thalassemic membrane protein content. No quantitative deficiency of ankyrin or protein 4.1 is detected when thalassemic ghosts and IOVs are studied using pyridine elution of Coomassie Bluestained gel bands (Table I) . There is no difference in sidedness between thalassemic and normal IOVs.
Protein 4.1 purified from thalassemic membranes has the same mobility on SDS-PAGE as normal 4.1 (Fig. 1 C) There is a small increase in the percentage of spectrin oligomers in the thalassemic extracts (thalassemic 38%; normal 29%) as evaluated by densitometry of low temperature extracts on 3% nondenaturing gels (Fig. 2 A; Table II) . We also detect a small amount (-4% of the total spectrin) of a fast mobility band migrating approximately in the position of spectrin monomer (26) in splenectomized patients with alpha (n = 1) and beta thalassemia (n = 4) (Fig. 2 B, Table II ). This was not observed in nonsplenectomized thalassemic patients or in either splenectomized or nonsplenectomized individuals. This band may represent oxidized spectrin (26) or a complex between spectrin and globin (31) .
In solution, equivalent proportions of alpha thalassemic, beta thalassemic, and normal spectrin tetramer convert to dimer (alpha thalassemic 92%; beta thalassemic 94%; normal 93%) during 6-h incubations at 30°C (data not shown).
Spectrin ankyrin interactions. The ankyrin binding sites of thalassemic spectrins are normal as assessed by rebinding alpha-or beta-thalassemic '251I-spectrin dimer (0-80 ,g/ml) to normal spectrin-depleted IOVs (Fig. 3 A) .
The binding of normal '251-spectrin to beta-thalassemic IOVs is also normal (Fig. 3 B) and comparable to that reported by Bennett and Branton (13) ; however, alpha-thalassemic IOVs bind less spectrin than normal IOVs (Fig. 3 B) . Scatchard analyses (Fig. 3 B, inset) (Fig. 4 A) . This normal binding ability is maintained when the assay is done in the absence of DTT (data not shown). This rules out the possibility that thalassemic spectrins undergo reversible oxidative damage that might have been corrected under the usual experimental conditions.
In contrast, the ability of beta-thalassemic protein 4.1 to enhance spectrin-actin interaction is abnormal. As shown in Fig. 4 B, beta-thalassemic protein 4.1 has markedly impaired ability to enhance the binding of normal spectrin dimer to actin (48±7% of normal), when compared with normal protein 4.1. The ability of alpha thalassemic protein 4.1 to interact with normal spectrin and actin is comparable to normal.
The binding of beta-thalassemic 4.1 to spectrin is also ab- 
Discussion
Previous indirect evidence suggests that skeletal membrane proteins of thalassemic erythrocytes are abnormal in shape, composition, and function (7, 8) . We, therefore, analyzed the different skeletal protein interactions in thalassermic red cells in search of specific defects. We found that such defects are relatively few in number and differ in alpha and beta thalassemia (Table III) . Spectrin, the major skeletal protein, incurred some slight damage in both alpha and beta thalassemia as shown by the presence of a trace amount of a fast mobility band on nondenaturing gels. Despite this limited structural alteration, thalassemic spectrin functions normally in spectrin self-association and in its interactions with other membrane skeletal proteins. (Fig. 3 B) . The (19, (38) (39) (40) , but it also binds to the red cell membrane via the glycophorins (41) (42) (43) and possibly protein 3 (44) , and phosphatidylserine (45) (46) (47) . Recent data show that it has a crucial role in regulating red cell membrane stability (48) . As previously mentioned, beta-thalassemic membranes show increased membrane fragility (7) . Similar fragility is observed in patients with total or partial RBC protein 4.1 deficiency (48, 49) as well as in defects involving spectrin self-association (50, 51) , spectrin-actin-4.1 interactions (47, 49) , and severe spectrin deficiency (6) . Beta-thalassemic red cells are moderately spectrin deficient (23% less spectrin than normal) and this deficiency may contribute to the observed membrane fragility (7); it is difficult to apportion the relative contributions of spectrin deficiency and the functional defect present in betathalassemic protein 4.1. The possibility that spectrin deficiency in thalassemic membranes may be secondary to the defects in spectrin-IOV binding (alpha thal) or spectrin-4.1 interactions (beta thal) must also be considered.
That different molecular defects exist in the skeletal proteins ofalpha-and beta-thalassemic red cells is ofgreat interest and supports our hypothesis that unpaired alpha and beta globin chains may bind to and damage the membrane in different ways. Indeed, previous electron microscopic data suggest that this might be the case, as the morphological appearance of nucleated, as well as mature RBC is different in alpha (51) and beta thalassemia (52) .
The loss of critical interactions between the core skeletal proteins (more evident in beta thalassemia), as well as interactions between the skeletal proteins and the overlying lipid bilayer (more evident in alpha thalassemia), might contribute to abnormal clustering oftransmembrane proteins. This, in turn, could stimulate binding of autologous immunoglobulins (53, 54) , and early recognition and removal of those erythrocytes from the circulation.
Further functional and structural studies are required for better understanding of the mechanism(s) responsible for such defects, and their role in the pathophysiology of the severe hemolysis in thalassemia.
